banner
HCV protease inhibitor PSI-6206 13CD3, Purity ≥98%
Inquiry

Cat. No.: X24-07-ZQ171

HCV protease inhibitor PSI-6206 13CD3, Purity ≥98%

Synonym: 1256490-42-2; HCV protease inhibitor; RO-2433 13CD3; GS-331007 13CD3; Sofosbuvir metabolite GS-331007 13CD3

  • CAS Number: 1256490-42-2
  • Compound CID: 58463518
img
Product Size
1 mg; 5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
PSI-6206 13CD3 targets and inhibits the function of the hepatitis C virus protease enzyme.
Molecular Weight
264.23
Molecular Formula
C10H10D3FN2O5
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
PSI-6206 13CD3 is analyzed for its potential to inhibit hepatitis C virus replication by interfering with the viral protease enzyme.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0